Insmed
INSM
#964
Rank
C$35.44 B
Marketcap
C$162.33
Share price
-1.29%
Change (1 day)
-17.70%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -C$1.1 Billion

According to Insmed's latest financial reports the company's current earnings are C$1.13 Billion. In 2025 the company made an earning of -C$1.7 Billion a decrease over its 2024 earnings that were of -C$1.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$1.1 Billion-35.41%
2025 -C$1.7 Billion43.91%
2024 -C$1.19 Billion23.71%
2023 -C$0.96 Billion45.77%
2022 -C$0.66 Billion15.83%
2021 -C$0.57 Billion50.19%
2020 -C$0.38 Billion16.4%
2019 -C$0.33 Billion-23.9%
2018 -C$0.43 Billion59.35%
2017 -C$0.27 Billion8.52%
2016 -C$0.25 Billion47.25%
2015 -C$0.17 Billion34.53%
2014 -C$0.13 Billion58.83%
2013 -C$78.06 Million35.14%
2012 -C$57.76 Million-31.92%
2011 -C$84.84 Million854.92%
2010 -C$8.89 Million-105.22%
2009 C$0.17 B-905.06%
2008 -C$21.13 Million-27.31%
2007 -C$29.07 Million-62.41%
2006 -C$77.33 Million98.19%
2005 -C$39.02 Million0.03%
2004 -C$39.01 Million159.07%
2003 -C$15.06 Million-69.31%
2002 -C$49.06 Million
2000 -C$44.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.07 B-2,056.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-C$2.79 Billion 146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$7.17 B-735.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-C$0.19 Billion-83.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-C$33.06 Million-97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-C$73.46 Million-93.49%๐Ÿ‡บ๐Ÿ‡ธ USA